• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高糖通过调控 miR-493-5p/ZEB2 信号抑制骨髓间充质干细胞成骨分化。

High glucose inhibits osteogenic differentiation of bone marrow mesenchymal stem cells via regulating miR-493-5p/ZEB2 signalling.

机构信息

Department of Endocrinology, The Affiliated Lianshui County People's Hospital of Kangda College of Nanjing Medical University, Huai'an, Jiangsu 223400, China.

Department of Imaging, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, Jiangsu 223002, China.

出版信息

J Biochem. 2020 Jun 1;167(6):613-621. doi: 10.1093/jb/mvaa011.

DOI:10.1093/jb/mvaa011
PMID:32463882
Abstract

Diabetic osteoporosis (DOP) is attributed to the aberrant physiological function of bone marrow mesenchymal stem cells (BMSCs) under high glucose (HG) environment. MicroRNAs (miRNAs) are involved in the pathological processes of DOP. We aimed to explore the underlying mechanism of miRNA in DOP. BMSCs were cultured in osteogenic medium with HG to induce osteogenic differentiation, and the interaction between miR-493-5p and ZEB2 was assessed by luciferase assay. Herein, we found miR-493-5p is gradually reduced during osteogenic differentiation in BMSCs. HG treatment inhibits osteogenic differentiation and induces an up-regulation of miR-493-5p leading to reduced level of its downstream target ZEB2. Inhibition of miR-493-5p attenuates HG-induced osteogenic differentiation defects by upregulation of ZEB2. Mechanistically, miR-493-5p/ZEB2 signalling mediates HG-inhibited osteogenic differentiation by inactivation of Wnt/β-catenin signalling. More importantly, knockdown of miR-493-5p therapeutically alleviated the DOP condition in mice. HG prevents BMSCs osteogenic differentiation via up-regulation of miR-493-5p, which results in reduced level of ZEB2 by directly targeting its 3'-untranslated region of mRNA. Thus, miR-493-5p/ZEB2 is a potential therapeutic target and provides novel strategy for the treatment and management of DOP.

摘要

糖尿病性骨质疏松症 (DOP) 归因于高糖 (HG) 环境下骨髓间充质干细胞 (BMSCs) 的异常生理功能。MicroRNAs (miRNAs) 参与 DOP 的病理过程。我们旨在探讨 miRNA 在 DOP 中的潜在机制。BMSCs 在成骨培养基中培养并接受 HG 处理以诱导成骨分化,并通过荧光素酶测定评估 miR-493-5p 与 ZEB2 之间的相互作用。在此,我们发现 miR-493-5p 在 BMSCs 的成骨分化过程中逐渐减少。HG 处理抑制成骨分化并诱导 miR-493-5p 的上调,导致其下游靶标 ZEB2 的水平降低。抑制 miR-493-5p 通过上调 ZEB2 减轻 HG 诱导的成骨分化缺陷。机制上,miR-493-5p/ZEB2 信号通过失活 Wnt/β-catenin 信号转导介导 HG 抑制的成骨分化。更重要的是,miR-493-5p 的敲低治疗性地缓解了小鼠的 DOP 状况。HG 通过上调 miR-493-5p 来阻止 BMSCs 的成骨分化,这导致 ZEB2 的水平降低,这是通过直接靶向其 mRNA 的 3'非翻译区实现的。因此,miR-493-5p/ZEB2 是一个有潜力的治疗靶点,并为 DOP 的治疗和管理提供了新策略。

相似文献

1
High glucose inhibits osteogenic differentiation of bone marrow mesenchymal stem cells via regulating miR-493-5p/ZEB2 signalling.高糖通过调控 miR-493-5p/ZEB2 信号抑制骨髓间充质干细胞成骨分化。
J Biochem. 2020 Jun 1;167(6):613-621. doi: 10.1093/jb/mvaa011.
2
Upregulated miR-9-5p inhibits osteogenic differentiation of bone marrow mesenchymal stem cells under high glucose treatment.高糖处理下上调的 miR-9-5p 抑制骨髓间充质干细胞的成骨分化。
J Bone Miner Metab. 2022 Mar;40(2):208-219. doi: 10.1007/s00774-021-01280-9. Epub 2021 Nov 9.
3
miR-124-3p promotes BMSC osteogenesis via suppressing the GSK-3β/β-catenin signaling pathway in diabetic osteoporosis rats.miR-124-3p 通过抑制糖尿病骨质疏松大鼠中的 GSK-3β/β-catenin 信号通路促进 BMSC 成骨。
In Vitro Cell Dev Biol Anim. 2020 Oct;56(9):723-734. doi: 10.1007/s11626-020-00502-0. Epub 2020 Oct 21.
4
The Inhibition of MicroRNA-139-5p Promoted Osteoporosis of Bone Marrow-Derived Mesenchymal Stem Cells by Targeting Wnt/Beta-Catenin Signaling Pathway by NOTCH1.NOTCH1 通过靶向 Wnt/β-联蛋白信号通路抑制微小 RNA-139-5p 促进骨髓间充质干细胞骨质疏松症。
J Microbiol Biotechnol. 2020 Mar 28;30(3):448-458. doi: 10.4014/jmb.1908.08036.
5
The lncRNA H19/miR-541-3p/Wnt/β-catenin axis plays a vital role in melatonin-mediated osteogenic differentiation of bone marrow mesenchymal stem cells.长链非编码 RNA H19/miR-541-3p/Wnt/β-catenin 轴在褪黑素介导的骨髓间充质干细胞成骨分化中起重要作用。
Aging (Albany NY). 2021 Jul 26;13(14):18257-18273. doi: 10.18632/aging.203267.
6
mir-150-5p inhibits the osteogenic differentiation of bone marrow-derived mesenchymal stem cells by targeting irisin to regulate the p38/MAPK signaling pathway.miR-150-5p 通过靶向鸢尾素调控 p38/MAPK 信号通路抑制骨髓间充质干细胞成骨分化。
J Orthop Surg Res. 2024 Mar 18;19(1):190. doi: 10.1186/s13018-024-04671-6.
7
Long noncoding RNA HCG18 inhibits the differentiation of human bone marrow-derived mesenchymal stem cells in osteoporosis by targeting miR-30a-5p/NOTCH1 axis.长链非编码 RNA HCG18 通过靶向 miR-30a-5p/NOTCH1 轴抑制骨质疏松症中人骨髓间充质干细胞的分化。
Mol Med. 2020 Nov 11;26(1):106. doi: 10.1186/s10020-020-00219-6.
8
MicroRNA-15a-5p plays a role in osteogenic MC3T3-E1 cells differentiation by targeting PDCD4 (programmed cell death 4) via Wnt/β-catenin dependent signaling pathway.微小 RNA-15a-5p 通过 Wnt/β-连环蛋白依赖性信号通路靶向 PDCD4(程序性细胞死亡 4)在成骨 MC3T3-E1 细胞分化中发挥作用。
Bioengineered. 2021 Dec;12(1):8173-8185. doi: 10.1080/21655979.2021.1977766.
9
miR-384-5p Targets and Negatively Regulates Age-Related Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells.miR-384-5p 靶向并负调控大鼠骨髓间充质干细胞的衰老相关成骨分化。
Stem Cells Dev. 2019 Jun 15;28(12):791-798. doi: 10.1089/scd.2019.0044. Epub 2019 May 20.
10
MicroRNA-92b-5p modulates melatonin-mediated osteogenic differentiation of bone marrow mesenchymal stem cells by targeting ICAM-1.微小 RNA-92b-5p 通过靶向细胞间黏附分子 1 调节褪黑素介导的骨髓间充质干细胞成骨分化。
J Cell Mol Med. 2019 Sep;23(9):6140-6153. doi: 10.1111/jcmm.14490. Epub 2019 Jul 14.

引用本文的文献

1
Inhibition of histone methyltransferase G9a promotes the osteogenic potential of bone-derived stem cells in diabetic-osteoporosis by regulating the LINC00657/miR-204-5p/IGFBP5 pathway.组蛋白甲基转移酶G9a的抑制通过调节LINC00657/miR-204-5p/IGFBP5途径促进糖尿病性骨质疏松症中骨源干细胞的成骨潜能。
Front Endocrinol (Lausanne). 2025 Aug 12;16:1625944. doi: 10.3389/fendo.2025.1625944. eCollection 2025.
2
Impaired nutrient absorption, reduced bone mass and alterations in the gut microbiome contribute to postnatal growth retardation in a mouse model of MWS.营养吸收受损、骨量减少以及肠道微生物群的改变导致了MWS小鼠模型中的出生后生长迟缓。
Sci Rep. 2025 Aug 22;15(1):30890. doi: 10.1038/s41598-025-16542-z.
3
Dualistic role of ZEB1 and ZEB2 in tumor progression.
ZEB1和ZEB2在肿瘤进展中的双重作用。
Biol Direct. 2025 Mar 20;20(1):32. doi: 10.1186/s13062-025-00604-3.
4
Syringin protects high glucose-induced BMSC injury, cell senescence, and osteoporosis by inhibiting JAK2/STAT3 signaling.紫丁香苷通过抑制JAK2/STAT3信号通路保护高糖诱导的骨髓间充质干细胞损伤、细胞衰老和骨质疏松。
J Appl Biomed. 2024 Dec;22(4):197-207. doi: 10.32725/jab.2024.021. Epub 2024 Oct 21.
5
The microbial metabolite imidazole propionate dysregulates bone homeostasis by inhibiting AMP-activated protein kinase (AMPK) signaling.微生物代谢产物咪唑丙酸通过抑制AMP活化蛋白激酶(AMPK)信号传导来破坏骨稳态。
Commun Biol. 2024 Dec 19;7(1):1644. doi: 10.1038/s42003-024-07316-w.
6
LncRNA SNHG14 activates autophagy via regulating miR-493-5p/Mef2c axis to alleviate osteoporosis progression.长链非编码 RNA SNHG14 通过调控 miR-493-5p/Mef2c 轴激活自噬来减轻骨质疏松症的进展。
Commun Biol. 2023 Nov 4;6(1):1120. doi: 10.1038/s42003-023-05493-8.
7
Expression of proinflammatory cytokines and proinsulin by bone marrow-derived cells for fracture healing in long-term diabetic mice.骨髓来源细胞在长期糖尿病小鼠骨折愈合中的促炎细胞因子和胰岛素原的表达。
BMC Musculoskelet Disord. 2023 Jul 18;24(1):585. doi: 10.1186/s12891-023-06710-5.
8
Osteogenesis of bone marrow mesenchymal stem cell in hyperglycemia.高血糖症下骨髓间充质干细胞的成骨作用。
Front Endocrinol (Lausanne). 2023 Jun 21;14:1150068. doi: 10.3389/fendo.2023.1150068. eCollection 2023.
9
Metformin attenuates diabetes-induced osteopenia in rats is associated with down-regulation of the RAGE-JAK2-STAT1 signal axis.二甲双胍减轻糖尿病诱导的大鼠骨质减少与RAGE-JAK2-STAT1信号轴的下调有关。
J Orthop Translat. 2023 Jun 3;40:37-48. doi: 10.1016/j.jot.2023.05.002. eCollection 2023 May.
10
P53 negatively regulates the osteogenic differentiation in jaw bone marrow MSCs derived from diabetic osteoporosis.P53负向调控糖尿病性骨质疏松症患者颌骨骨髓间充质干细胞的成骨分化。
Heliyon. 2023 Apr 3;9(4):e15188. doi: 10.1016/j.heliyon.2023.e15188. eCollection 2023 Apr.